Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verona Pharma plc

90.48
-4.1000-4.33%
Post-market: 90.850.3700+0.41%19:25 EDT
Volume:1.83M
Turnover:167.21M
Market Cap:7.70B
PE:-44.84
High:97.44
Open:96.59
Low:89.78
Close:94.58
Loading ...

Verona Pharma Initiated at Outperform by Wolfe Research

Dow Jones
·
Yesterday

Verona Pharma initiated with an Outperform at Wolfe Research

TIPRANKS
·
Yesterday

Verona Pharma Is Maintained at Overweight by Piper Sandler

Dow Jones
·
24 Jun

Verona Pharma Plc : Piper Sandler Raises Target Price to $160.00 From $76.00

THOMSON REUTERS
·
23 Jun

Verona Pharma Is Maintained at Overweight by Wells Fargo

Dow Jones
·
20 Jun

Verona Pharma's General Counsel Andrew Fisher Reports Disposal of Common Shares

Reuters
·
19 Jun

Verona Pharma price target raised to $116 from $92 at Roth Capital

TIPRANKS
·
18 Jun

David Zaccardelli, President and CEO, Reports Disposal of Common Shares of Verona Pharma plc

Reuters
·
14 Jun

European Equities Traded in the US as American Depositary Receipts Rise Wednesday

MT Newswires Live
·
11 Jun

Verona Pharma Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
11 Jun

Verona Pharma price target raised to $110 from $95 at Jefferies

TIPRANKS
·
11 Jun

European Equities Traded in the US as American Depositary Receipts Advance Friday

MT Newswires Live
·
06 Jun

Piper Sandler Remains a Buy on Verona Pharma (VRNA)

TIPRANKS
·
05 Jun

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
02 Jun

Verona Pharma Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
02 Jun

Verona Pharma Plc : H.c. Wainwright Raises Target Price to $90 From $85

THOMSON REUTERS
·
02 Jun

Jefferies Sticks to Its Buy Rating for Verona Pharma (VRNA)

TIPRANKS
·
31 May

European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading

MT Newswires Live
·
30 May

Jim Cramer Notes Verona Pharma plc (VRNA) “Loses a Lot of Money”

Insider Monkey
·
30 May

CFO Mark W. Hahn Reports Disposal of Common Shares of Verona Pharma plc

Reuters
·
30 May